Advertisement

The dose-dependent effect of SOX9 and its incidence in colorectal cancer

  • Corinne Prévostel
    Correspondence
    Corresponding author: IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, F-34298, France.
    Affiliations
    IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, F-34298, France

    INSERM, U1194, Montpellier, F-34298, France

    Université de Montpellier, Montpellier, F-34090, France

    Institut régional du Cancer de Montpellier, Montpellier, F-34298, France
    Search for articles by this author
  • Philippe Blache
    Correspondence
    Corresponding author: IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, F-34298, France.
    Affiliations
    IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, F-34298, France

    INSERM, U1194, Montpellier, F-34298, France

    Université de Montpellier, Montpellier, F-34090, France

    Institut régional du Cancer de Montpellier, Montpellier, F-34298, France
    Search for articles by this author
Published:October 06, 2017DOI:https://doi.org/10.1016/j.ejca.2017.08.037

      Highlights

      • SOX9 has a dose-dependent effect in intestine epithelial cells.
      • High dose of SOX9 is found in quiescent reserve intestinal stem cells.
      • Low dose of SOX9 is found in actively proliferating intestinal stem cells.
      • High level of SOX9 predicts a low risk of relapse in stage II CRC.
      • 10% of colorectal cancers exhibit heterozygous inactivating mutations of SOX9.

      Abstract

      A member of the Sry-related HMG-box family of transcription factors (SOX9) is a transcription factor that belongs to the superfamily of High Mobility Group (HMG) domain transcription factors. SOX9 is expressed in a variety of tissues, including as the intestinal epithelium, where it is now recognised as an important actor for homeostasis. Beside, a high level of SOX9 has recently been correlated with a good prognosis for stage II colorectal cancers. However, growing evidence indicates that deciphering the function of SOX9 in the intestine has to take into account a dose-dependent effect of SOX9. Given the recurrent controversies and the lack of a state of the art as to whether SOX9 behaves like a tumour suppressor or an oncogen in the intestine epithelium, it is time to provide an update of the accumulated knowledge about the biological function of SOX9 in the intestine and about the role of SOX9 in colorectal cancers.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gubbay J.
        • Koopman P.
        • Collignon J.
        • Burgoyne P.
        • Lovell-Badge R.
        Normal structure and expression of Zfy genes in XY female mice mutant in Tdy.
        Development. 1990; 109: 647-653
        • Sinclair A.H.
        • Berta P.
        • Palmer M.S.
        • Hawkins J.R.
        • Griffiths B.L.
        • Smith M.J.
        • et al.
        A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif.
        Nature. 1990; 346: 240-244
        • Harley V.R.
        • Lovell-Badge R.
        • Goodfellow P.N.
        Definition of a consensus DNA binding site for SRY.
        Nucleic Acids Res. 1994; 22: 1500-1501
        • Weiss M.A.
        Floppy SOX: mutual induced fit in hmg (high-mobility group) box-DNA recognition.
        Mol Endocrinol. 2001; 15: 353-362
        • Dupasquier S.
        • Abdel-Samad R.
        • Glazer R.I.
        • Bastide P.
        • Jay P.
        • Joubert D.
        • et al.
        A new mechanism of SOX9 action to regulate PKCalpha expression in the intestine epithelium.
        J Cell Sci. 2009; 122: 2191-2196
        • Prevostel C.
        • Rammah-Bouazza C.
        • Trauchessec H.
        • Canterel-Thouennon L.
        • Busson M.
        • Ychou M.
        • et al.
        SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ss-catenin signaling.
        Oncotarget. 2016;
        • Foster J.W.
        Mutations in SOX9 cause both autosomal sex reversal and campomelic dysplasia.
        Acta Paediatr Jpn. 1996; 38: 405-411
        • Pritchett J.
        • Athwal V.
        • Roberts N.
        • Hanley N.A.
        • Hanley K.P.
        Understanding the role of SOX9 in acquired diseases: lessons from development.
        Trends Mol Med. 2011; 17: 166-174
        • Hiramatsu R.
        • Matoba S.
        • Kanai-Azuma M.
        • Tsunekawa N.
        • Katoh-Fukui Y.
        • Kurohmaru M.
        • et al.
        A critical time window of Sry action in gonadal sex determination in mice.
        Development. 2009; 136: 129-138
        • De Santa Barbara P.
        • Bonneaud N.
        • Boizet B.
        • Desclozeaux M.
        • Moniot B.
        • Sudbeck P.
        • et al.
        Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene.
        Mol Cell Biol. 1998; 18: 6653-6665
        • Lefebvre V.
        • de Crombrugghe B.
        Toward understanding SOX9 function in chondrocyte differentiation.
        Matrix Biol. 1998; 16: 529-540
        • Stolt C.C.
        • Lommes P.
        • Sock E.
        • Chaboissier M.C.
        • Schedl A.
        • Wegner M.
        The Sox9 transcription factor determines glial fate choice in the developing spinal cord.
        Genes Dev. 2003; 17: 1677-1689
        • Perl A.K.
        • Kist R.
        • Shan Z.
        • Scherer G.
        • Whitsett J.A.
        Normal lung development and function after Sox9 inactivation in the respiratory epithelium.
        Genesis. 2005; 41: 23-32
        • Seymour P.A.
        • Freude K.K.
        • Tran M.N.
        • Mayes E.E.
        • Jensen J.
        • Kist R.
        • et al.
        SOX9 is required for maintenance of the pancreatic progenitor cell pool.
        Proc Natl Acad Sci U S A. 2007; 104: 1865-1870
        • Vidal V.P.
        • Chaboissier M.C.
        • Lutzkendorf S.
        • Cotsarelis G.
        • Mill P.
        • Hui C.C.
        • et al.
        Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment.
        Curr Biol. 2005; 15: 1340-1351
        • Poche R.A.
        • Furuta Y.
        • Chaboissier M.C.
        • Schedl A.
        • Behringer R.R.
        Sox9 is expressed in mouse multipotent retinal progenitor cells and functions in Muller glial cell development.
        J Comp Neurol. 2008; 510: 237-250
        • Reginensi A.
        • Clarkson M.
        • Neirijnck Y.
        • Lu B.
        • Ohyama T.
        • Groves A.K.
        • et al.
        SOX9 controls epithelial branching by activating RET effector genes during kidney development.
        Hum Mol Genet. 2011; 20: 1143-1153
        • Lincoln J.
        • Kist R.
        • Scherer G.
        • Yutzey K.E.
        Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development.
        Dev Biol. 2007; 305: 120-132
        • Antoniou A.
        • Raynaud P.
        • Cordi S.
        • Zong Y.
        • Tronche F.
        • Stanger B.Z.
        • et al.
        Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9.
        Gastroenterology. 2009; 136: 2325-2333
        • Thomsen M.K.
        • Butler C.M.
        • Shen M.M.
        • Swain A.
        Sox9 is required for prostate development.
        Dev Biol. 2008;
        • Jo A.
        • Denduluri S.
        • Zhang B.
        • Wang Z.
        • Yin L.
        • Yan Z.
        • et al.
        The versatile functions of Sox9 in development, stem cells, and human diseases.
        Genes Dis. 2014; 1: 149-161
        • Drivdahl R.
        • Haugk K.H.
        • Sprenger C.C.
        • Nelson P.S.
        • Tennant M.K.
        • Plymate S.R.
        Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9.
        Oncogene. 2004; 23: 4584-4593
        • Wang H.
        • Leav I.
        • Ibaragi S.
        • Wegner M.
        • Hu G.F.
        • Lu M.L.
        • et al.
        SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion.
        Cancer Res. 2008; 68: 1625-1630
        • Vidal V.P.
        • Ortonne N.
        • Schedl A.
        SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms.
        J Cutan Pathol. 2008; 35: 373-379
        • Passeron T.
        • Valencia J.C.
        • Namiki T.
        • Vieira W.D.
        • Passeron H.
        • Miyamura Y.
        • et al.
        Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid.
        J Clin Invest. 2009; 119: 954-963
        • Swartling F.J.
        • Ferletta M.
        • Kastemar M.
        • Weiss W.A.
        • Westermark B.
        Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines.
        Oncogene. 2009; 28: 3121-3131
        • Kato N.
        • Fukase M.
        • Motoyama T.
        Expression of a transcription factor, SOX9, in Sertoli-stromal cell tumors of the ovary.
        Int J Gynecol Pathol. 2004; 23: 180-181
        • Zhou C.H.
        • Ye L.P.
        • Ye S.X.
        • Li Y.
        • Zhang X.Y.
        • Xu X.Y.
        • et al.
        Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.
        J Exp Clin Cancer Res. 2012; 31: 18
        • Muller P.
        • Crofts J.D.
        • Newman B.S.
        • Bridgewater L.C.
        • Lin C.Y.
        • Gustafsson J.A.
        • et al.
        SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells.
        Breast Cancer Res Treat. 2010; 120: 317-326
        • Riemenschnitter C.
        • Teleki I.
        • Tischler V.
        • Guo W.
        • Varga Z.
        Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy.
        Springer Plus. 2013; 2: 695
        • Guo X.
        • Xiong L.
        • Sun T.
        • Peng R.
        • Zou L.
        • Zhu H.
        • et al.
        Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
        Diagn Pathol. 2012; 7: 44
        • Leung C.O.
        • Mak W.N.
        • Kai A.K.
        • Chan K.S.
        • Lee T.K.
        • Ng I.O.
        • et al.
        Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/beta-catenin signaling.
        Oncotarget. 2016; 7: 29371-29386
        • Prevot P.P.
        • Simion A.
        • Grimont A.
        • Colletti M.
        • Khalaileh A.
        • Van den Steen G.
        • et al.
        Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia.
        Gut. 2012; 61: 1723-1732
        • Tanaka T.
        • Kuroki T.
        • Adachi T.
        • Ono S.
        • Hirabaru M.
        • Soyama A.
        • et al.
        Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
        Pancreas. 2013; 42: 488-493
        • Blache P.
        • Van De Wetering M.
        • Duluc I.
        • Domon C.
        • Berta P.
        • Freund J.N.
        • et al.
        SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes.
        J Cell Biol. 2004; 166: 37-47
        • Bastide P.
        • Darido C.
        • Pannequin J.
        • Kist R.
        • Robine S.
        • Marty-Double C.
        • et al.
        Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium.
        J Cell Biol. 2007; 178: 635-648
        • Mori-Akiyama Y.
        • van den Born M.
        • van Es J.H.
        • Hamilton S.R.
        • Adams H.P.
        • Zhang J.
        • et al.
        SOX9 is required for the differentiation of paneth cells in the intestinal epithelium.
        Gastroenterology. 2007; 133: 539-546
        • Guilmeau S.
        • Flandez M.
        • Bancroft L.
        • Sellers R.S.
        • Tear B.
        • Stanley P.
        • et al.
        Intestinal deletion of Pofut1 in the mouse inactivates notch signaling and causes enterocolitis.
        Gastroenterology. 2008; 135: 849-860, 860.e1–6
        • Formeister E.J.
        • Sionas A.L.
        • Lorance D.K.
        • Barkley C.L.
        • Lee G.H.
        • Magness S.T.
        Distinct SOX9 levels differentially mark stem/progenitor populations and enteroendocrine cells of the small intestine epithelium.
        Am J Physiol Gastrointest Liver Physiol. 2009; 296: G1108-G1118
        • Roche K.C.
        • Gracz A.D.
        • Liu X.F.
        • Newton V.
        • Akiyama H.
        • Magness S.T.
        SOX9 maintains reserve stem cells and preserves radioresistance in mouse small intestine.
        Gastroenterology. 2015, Nov; 149: 1553-1563.e10
        • Shi Z.
        • Chiang C.I.
        • Mistretta T.A.
        • Major A.
        • Mori-Akiyama Y.
        SOX9 directly regulates IGFBP-4 in the intestinal epithelium.
        Am J Physiol Gastrointest Liver Physiol. 2013; 305: G74-G83
        • Dzobo K.
        • Senthebane D.A.
        • Rowe A.
        • Thomford N.E.
        • Mwapagha L.M.
        • Al-Awwad N.
        • et al.
        Cancer stem cell hypothesis for therapeutic innovation in clinical oncology? Taking the root out, notchopping the leaf.
        Omics. 2016; 20: 681-691
        • Sukach A.N.
        • Ivanov E.N.
        Formation of spherical colonies as a property of stem cells.
        Tsitologiia. 2007; 49: 916-922
        • Ablaza S.G.
        • Blanco G.
        • Maranhao V.
        • Goldberg H.
        Total replacement of aortic valve in a patient with internal pacemaker; report of a case.
        Arch Surg. 1965; 90: 694-697
        • Jay P.
        • Berta P.
        • Blache P.
        Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells.
        Cancer Res. 2005; 65: 2193-2198
        • Nittka S.
        • Gunther J.
        • Ebisch C.
        • Erbersdobler A.
        • Neumaier M.
        The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis.
        Oncogene. 2004; 23: 9306-9313
        • Zalzali H.
        • Naudin C.
        • Bastide P.
        • Quittau-Prevostel C.
        • Yaghi C.
        • Poulat F.
        • et al.
        CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium.
        Oncogene. 2008; 27: 7131-7138
        • Abdel-Samad R.
        • Zalzali H.
        • Rammah C.
        • Giraud J.
        • Naudin C.
        • Dupasquier S.
        • et al.
        MiniSOX9, a dominant-negative variant in colon cancer cells.
        Oncogene. 2011; 30: 2493-2503
        • Topol L.
        • Chen W.
        • Song H.
        • Day T.F.
        • Yang Y.
        Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus.
        J Biol Chem. 2009; 284: 3323-3333
        • Sansom O.J.
        • Meniel V.S.
        • Muncan V.
        • Phesse T.J.
        • Wilkins J.A.
        • Reed K.R.
        • et al.
        Myc deletion rescues Apc deficiency in the small intestine.
        Nature. 2007; 446: 676-679
        • MarckerEspersen M.L.
        • Linnemann D.
        • Christensen I.J.
        • Alamili M.
        • Troelsen J.T.
        • Hogdall E.
        SOX9 expression predicts relapse of stage II colon cancer patients.
        Hum Pathol. 2016; 52: 38-46
        • Lu B.
        • Fang Y.
        • Xu J.
        • Wang L.
        • Xu F.
        • Xu E.
        • et al.
        Analysis of SOX9 expression in colorectal cancer.
        Am J Clin Pathol. 2008; 130: 897-904
        • Bruun J.
        • Kolberg M.
        • Nesland J.M.
        • Svindland A.
        • Nesbakken A.
        • Lothe R.A.
        Prognostic significance of beta-catenin, E-cadherin, and SOX9 in colorectal cancer: results from alarge population-representative series.
        Front Oncol. 2014; 4: 118
      1. Comprehensive molecular characterization of human colon and rectal cancer.
        Nature. 2012; 487: 330-337
        • Casellas F.
        • Herrera-de Guise C.
        • Robles V.
        • Navarro E.
        • Borruel N.
        Patient preferences for inflammatory bowel disease treatment objectives.
        Dig Liver Dis. 2016;
        • Abrams J.A.
        • Javier S.J.
        • Maxwell M.L.
        • Belgrave F.Z.
        • Nguyen B.A.
        Distant but relative: similarities and differences in gender role beliefs among African American and Vietnamese American women.
        Cult Divers Ethn Minority Psychol. 2016; 22: 256-267
        • Matheu A.
        • Collado M.
        • Wise C.
        • Manterola L.
        • Cekaite L.
        • Tye A.J.
        • et al.
        Oncogenicity of the developmental transcription factor Sox9.
        Cancer Res. 2012; 72: 1301-1315
        • Shen Z.
        • Deng H.
        • Fang Y.
        • Zhu X.
        • Ye G.T.
        • Yan L.
        • et al.
        Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
        Oncotarget. 2015; 6: 20672-20684
        • Carrasco-Garcia E.
        • Lopez L.
        • Aldaz P.
        • Arevalo S.
        • Aldaregia J.
        • Egana L.
        • et al.
        SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin.
        Sci Rep. 2016; 6: 32350
        • Castle J.C.
        • Loewer M.
        • Boegel S.
        • de Graaf J.
        • Bender C.
        • Tadmor A.D.
        • et al.
        Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma.
        BMC Genomics. 2014; 15: 190
        • Wissmuller S.
        • Kosian T.
        • Wolf M.
        • Finzsch M.
        • Wegner M.
        The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors.
        Nucleic Acids Res. 2006; 34: 1735-1744
        • Shi Z.
        • Chiang C.I.
        • Labhart P.
        • Zhao Y.
        • Yang J.
        • Mistretta T.A.
        • et al.
        Context-specific role of SOX9 in NF-Y mediated gene regulation in colorectal cancer cells.
        Nucleic Acids Res. 2015; 43: 6257-6269